Artificial intelligence has dominated investor attention for two years, but biotech revenue lines are also bending sharply higher.
3 Biotech Stocks to Watch for Respectable Growth Beyond AI
Artificial intelligence has dominated investor attention for two years, but biotech revenue lines are also bending sharply higher.